HICP - Tea, mate and other plant-derived products for infusion (ND) in Greece

Greece: HICP - Tea, mate and other plant-derived products for infusion (ND) was 0.45 in 2026. ◆ Volatile

Latest (2026)
0.45
Change on year
up 28.6%
World rank
25th
of 27 countries
All-time high
0.5
in 2022
All-time low
0.07
in 2002
Years of data
31
1996–2026

HICP - Tea, mate and other plant-derived products for infusion (ND) in Greece, 1996–2026

0.10.20.30.40.51996201120261996: 0.131997: 0.131998: 0.131999: 0.122000: 0.112001: 0.092002: 0.072003: 0.072004: 0.072005: 0.072006: 0.072007: 0.072008: 0.072009: 0.072010: 0.072011: 0.132012: 0.142013: 0.142014: 0.172015: 0.272016: 0.322017: 0.292018: 0.252019: 0.32020: 0.282021: 0.442022: 0.52023: 0.422024: 0.422025: 0.352026: 0.45

Source: European Central Bank.

Analysis

In 2026, hicp - tea, mate and other plant-derived products for infusion (nd) in Greece stood at 0.45.

The figure is up 28.6% on the previous year and up 40.6% over ten years.

Over the whole period, hicp - tea, mate and other plant-derived products for infusion (nd) in Greece peaked at 0.5 in 2022 and was at its lowest, 0.07, in 2002.

Greece ranks 25th of 27 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

HICP - Tea, mate and other plant-derived products for infusion (ND) in Greece, year by year

Annual values for HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight) in Greece, 1996 to 2026.
Year Value Change
1996 0.13
1997 0.13 +0.0%
1998 0.13 +0.0%
1999 0.12 -7.7%
2000 0.11 -8.3%
2001 0.09 -18.2%
2002 0.07 -22.2%
2003 0.07 +0.0%
2004 0.07 +0.0%
2005 0.07 +0.0%
2006 0.07 +0.0%
2007 0.07 +0.0%
2008 0.07 +0.0%
2009 0.07 +0.0%
2010 0.07 +0.0%
2011 0.13 +85.7%
2012 0.14 +7.7%
2013 0.14 +0.0%
2014 0.17 +21.4%
2015 0.27 +58.8%
2016 0.32 +18.5%
2017 0.29 -9.4%
2018 0.25 -13.8%
2019 0.3 +20.0%
2020 0.28 -6.7%
2021 0.44 +57.1%
2022 0.5 +13.6%
2023 0.42 -16.0%
2024 0.42 +0.0%
2025 0.35 -16.7%
2026 0.45 +28.6%

Greece compared with similar countries

  • Greece's 0.45 is below the median for Europe & Central Asia, which is 0.92, 49% of the median. (26 countries reporting)
  • Greece's 0.45 is below the median for high income countries, which is 0.92, 49% of the median. (27 countries reporting)

Biggest year-on-year movements

Years where HICP - Tea, mate and other plant-derived products for infusion (ND) in Greece changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2011 +85.7% 0.07 0.13

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.1275 0.12 0.13 4
2000s 0.076 0.07 0.11 10
2010s 0.208 0.07 0.32 10
2020s 0.4086 0.28 0.5 7

Countries ranked near Greece

  1. 22 Luxembourg 0.5 compare
  2. 22 Romania 0.5 compare
  3. 24 Netherlands 0.48 compare
  4. 26 Cyprus 0.44 compare
  5. 27 Finland 0.38 compare

See the full ranking of 29 places →

More economy & growth data for Greece

All data for Greece →

Frequently asked questions

What is hicp - tea, mate and other plant-derived products for infusion (nd) in Greece?
Hicp - tea, mate and other plant-derived products for infusion (nd) in Greece was 0.45 in 2026, according to European Central Bank.
What is the highest hicp - tea, mate and other plant-derived products for infusion (nd) recorded in Greece?
The highest recorded value was 0.5 in 2022.
What is the lowest hicp - tea, mate and other plant-derived products for infusion (nd) recorded in Greece?
The lowest recorded value was 0.07 in 2002.
How does Greece rank for hicp - tea, mate and other plant-derived products for infusion (nd)?
Greece ranks 25th out of 27 countries with data for 2026.
Is hicp - tea, mate and other plant-derived products for infusion (nd) rising or falling in Greece?
Over the last ten years it is up 40.6%. The long-run trend across the full record is volatile.
Where does this Greece data come from?
The figures come from European Central Bank, published as part of HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 31 observations, free to reuse under ECB Terms and Conditions (attribution required).

Share, cite or embed this page

Cite this page

HICP - Tea, mate and other plant-derived products for infusion (ND) in Greece. Statizoid, drawing on European Central Bank. Retrieved 19 September 2026, from https://economy.statizoid.com/stat/hicp-tea-mate-and-other-plant-derived-products-for-infusion-nd-neither-seasonally-nor/greece/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under ECB Terms and Conditions (attribution required); please keep the attribution.

<a href="https://economy.statizoid.com/stat/hicp-tea-mate-and-other-plant-derived-products-for-infusion-nd-neither-seasonally-nor/greece/">HICP - Tea, mate and other plant-derived products for infusion (ND) in Greece</a> — Statizoid

About this data

Indicator
HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight)
Source
European Central Bank
Licence
ECB Terms and Conditions (attribution required)
Coverage
29 places, 853 data points, 1996–2026
Last refreshed